ArticleInternational journal of molecular sciences2026
Long-Term Consumption of Hyaluronan Increases Its Endogenous Levels Correlating with Attenuated Acute Alcohol-Induced Liver Injury.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Inflammation and oxidative stress play important roles in alcohol-induced liver injury. Hyaluronan (HA), a naturally occurring polysaccharide proven to exhibit antioxidant and anti-inflammatory functions, has garnered growing research attention in the field of food in recent years. This study demonstrates that long-term oral administration of HA exerts a protective effect against acute alcohol-induced liver injury (AALI). The findings showed that oral administration of 30, 600, and 1250 kDa HA for 2 and 4 weeks all increased serum and liver HA levels in rats and regulated the composition and abundance of gut microbiota. Meanwhile, oral HA could alleviate the symptoms of liver injury caused by alcohol, including increasing glutathione (GSH) levels, reducing malondialdehyde (MDA) and triglyceride (TG) levels, and decreasing the content of inflammatory factors interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α) compared with the AALI model mice. Furthermore, HA could inhibit the increase in reactive oxygen species (ROS) levels in AML12 cells induced by alcohol and improve the survival rate of alcohol-damaged AML12 cells. In conclusion, this study found that oral administration of HA could increase serum and liver HA levels and has a protective effect on AALI, suggesting the application of HA in health foods for hangover relief and liver protection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.